The Banco Sabadell Foundation is funding the first seroprevalence study of Covid-19 carried out by the Parc Taulí Hospital in Sabadell.
This is a groundbreaking study into the immune response among the hospital’s medical staff and a large group of patients, as well as in the target population in the city and region of Sabadell.
It aims to determine what proportion of the population has developed immunity to Covid-19 and to measure their antibody response in order to steer future efforts to protect people from the virus.
